General Info
Location: 3900 Essex Lane
Country: United States of America
Industries: biotech, pharmaceuticals, medical devices, life sciences
Investment Regions:
Investment Stages: seed
Website: http://www.fannininnovation.com/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Latest identifiable investment-related activity: Allterum Therapeutics Series Seed / grants and Pulmotect/Procyrion updates show activity in 2025 (Allterum PR dated Dec 17, 2020 earlier; however site news indicates Pulmotect and Procyrion items in 2024 and Allterum clinical/seed activity noted in 2025 press coverage such as Allterum clinical trial coverage Oct 10, 2025). The most recent clear investment-related event tied to Fannin Innovation Studio is Allterum/Procyrion/Pulmotect news within the past 6 months to 3 months timeframe prior to the reference date, indicating the last known investment happened between 6 and 3 months ago. The startup involved: Allterum Therapeutics.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Atul …
Managing Partner
Mark …
CFO
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Fannin Innovation Studio
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI